作者: Conrad A. Baldamus , Manfred Pollok
DOI: 10.1007/978-94-009-1087-4_14
关键词: Hypertension control 、 Intensive care medicine 、 Dialysis 、 Medicine 、 Hemofiltration 、 Continuous ambulatory peritoneal dialysis 、 Flat sheet 、 Ultrafiltration (renal)
摘要: The modern era of hemofiltration began with its clinical application in 1976. Before that, Henderson and colleagues (1, 2), Quellhorst associates (3–6), Dorson Markowitz (7, 8) had contributed to the physical principles (9, 10), reported first results (6) recycled purified ultrafiltrate (11). This work would have been inconceivable without membrane technology developed by industrial firms, such as Amicon (9) Sartorius (3). dialysis community became curious about new when 1976 workshop on was held Braunlage (Table 1) initiated German group Quellhorst. At this meeting a variety benefits were (12) including improvement anemia, neuropathy, lipid metabolism, hypertension control, hyperparathyroidism symptomatology. impressive list advantages recommended panacea end-stage renal disease (ESRD) treatment. Thereafter industry automatic balancing equipment (13) volumetric or gravimetric basis different membranes for flat sheet hollow fiber filters; simultaneously complicated dynamics fluid solute transfer 10) elucidated.